142 related articles for article (PubMed ID: 12576484)
1. Endothelial cell overexpression of fas ligand attenuates ischemia-reperfusion injury in the heart.
Yang J; Jones SP; Suhara T; Greer JJ; Ware PD; Nguyen NP; Perlman H; Nelson DP; Lefer DJ; Walsh K
J Biol Chem; 2003 Apr; 278(17):15185-91. PubMed ID: 12576484
[TBL] [Abstract][Full Text] [Related]
2. Antibody binding to fas ligand attenuates inflammatory cell infiltration and cytokine secretion, leading to reduction of myocardial infarct areas and reperfusion injury.
Shiraishi H; Toyozaki T; Tsukamoto Y; Saito T; Masuda Y; Hiroshima K; Ohwada H; Kobayashi N; Hiroe M
Lab Invest; 2002 Sep; 82(9):1121-9. PubMed ID: 12218072
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of human copper/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts.
Tanaka M; Mokhtari GK; Terry RD; Balsam LB; Lee KH; Kofidis T; Tsao PS; Robbins RC
Circulation; 2004 Sep; 110(11 Suppl 1):II200-6. PubMed ID: 15364863
[TBL] [Abstract][Full Text] [Related]
4. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
5. Fas/FasL induces myocardial cell apoptosis in myocardial ischemia-reperfusion rat model.
Liu XM; Yang ZM; Liu XK
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2913-2918. PubMed ID: 28682425
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory consequences of transgenic fas ligand expression in the heart.
Nelson DP; Setser E; Hall DG; Schwartz SM; Hewitt T; Klevitsky R; Osinska H; Bellgrau D; Duke RC; Robbins J
J Clin Invest; 2000 May; 105(9):1199-208. PubMed ID: 10791994
[TBL] [Abstract][Full Text] [Related]
7. Accelerated rejection of Fas ligand-expressing heart grafts.
Takeuchi T; Ueki T; Nishimatsu H; Kajiwara T; Ishida T; Jishage K; Ueda O; Suzuki H; Li B; Moriyama N; Kitamura T
J Immunol; 1999 Jan; 162(1):518-22. PubMed ID: 9886428
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia.
Jeremias I; Kupatt C; Martin-Villalba A; Habazettl H; Schenkel J; Boekstegers P; Debatin KM
Circulation; 2000 Aug; 102(8):915-20. PubMed ID: 10952962
[TBL] [Abstract][Full Text] [Related]
10. Vascular Endothelial Growth Factor-B Overexpressing Hearts Are Not Protected From Transplant-Associated Ischemia-Reperfusion Injury.
Raissadati A; Tuuminen R; Dashkevich A; Bry M; Kivelä R; Anisimov A; Syrjälä S; Arnaudova R; Rouvinen E; Keränen MA; Krebs R; Nykänen AI; Lemström KB
Exp Clin Transplant; 2017 Apr; 15(2):203-212. PubMed ID: 27588416
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury.
Chen Z; Oberley TD; Ho Y; Chua CC; Siu B; Hamdy RC; Epstein CJ; Chua BH
Free Radic Biol Med; 2000 Oct; 29(7):589-96. PubMed ID: 11033410
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury.
Zhou X; Fan GC; Ren X; Waggoner JR; Gregory KN; Chen G; Jones WK; Kranias EG
Cardiovasc Res; 2007 Aug; 75(3):487-97. PubMed ID: 17499229
[TBL] [Abstract][Full Text] [Related]
13. Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury.
Li G; Chen Y; Saari JT; Kang YJ
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1090-5. PubMed ID: 9321793
[TBL] [Abstract][Full Text] [Related]
14. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo.
Lee P; Sata M; Lefer DJ; Factor SM; Walsh K; Kitsis RN
Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H456-63. PubMed ID: 12414449
[TBL] [Abstract][Full Text] [Related]
15. Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury.
McCully JD; Wakiyama H; Hsieh YJ; Jones M; Levitsky S
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1923-35. PubMed ID: 14715509
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.
Yue TL; Ma XL; Wang X; Romanic AM; Liu GL; Louden C; Gu JL; Kumar S; Poste G; Ruffolo RR; Feuerstein GZ
Circ Res; 1998 Feb; 82(2):166-74. PubMed ID: 9468187
[TBL] [Abstract][Full Text] [Related]
17. Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection.
Tarzami ST; Miao W; Mani K; Lopez L; Factor SM; Berman JW; Kitsis RN
Circulation; 2003 Nov; 108(19):2387-92. PubMed ID: 14568904
[TBL] [Abstract][Full Text] [Related]
18. Genetic deletion of fas receptors or Fas ligands does not reduce infarct size after acute global ischemia-reperfusion in isolated mouse heart.
Tekin D; Xi L; Kukreja RC
Cell Biochem Biophys; 2006; 44(1):111-7. PubMed ID: 16456239
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury.
Jones SP; Greer JJ; Kakkar AK; Ware PD; Turnage RH; Hicks M; van Haperen R; de Crom R; Kawashima S; Yokoyama M; Lefer DJ
Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H276-82. PubMed ID: 12969888
[TBL] [Abstract][Full Text] [Related]
20. Myocardial and endothelial protection by TMS in ischemia-reperfusion injury.
Murohara T; Buerke M; Margiotta J; Ruan F; Igarashi Y; Hakomori S; Lefer AM
Am J Physiol; 1995 Aug; 269(2 Pt 2):H504-14. PubMed ID: 7544541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
